BETA Technologies, Inc Class A Common Stock Stock Price Today (NSE: BETA)
Fundamental Score
BETA Technologies, Inc Class A Common Stock Share Price — Live NSE/BSE Price, Fundamentals & Analysis
BETA Technologies, Inc Class A Common Stock share price today is ₹1661.10, up +0.00% on NSE/BSE as of 31 July 2026. BETA Technologies, Inc Class A Common Stock (BETA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹2.34K (Cr). The 52-week high for BETA share price is ₹2000.00 and the 52-week low is ₹1529.00. At a P/E ratio of 56.33x, BETA is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 18.78% and a debt-to-equity ratio of 0.60.
BETA Technologies, Inc Class A Common Stock Share Price Chart — NSE/BSE Historical Performance
BETA Technologies, Inc Class A Common Stock share price chart: -8.75% return over the past month. 52-week high ₹2000.00, 52-week low ₹1529.00.
BETA Technologies, Inc Class A Common Stock — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1615.00 | ₹1681.00 | ₹1602.10 | ₹1661.10 | 7.88K (Cr) | |
| ₹1642.00 | ₹1688.70 | ₹1642.00 | ₹1653.00 | 2.73K (Cr) | |
| ₹1664.00 | ₹1670.00 | ₹1529.00 | ₹1654.00 | 4.72K (Cr) | |
| ₹1689.95 | ₹1689.95 | ₹1652.05 | ₹1666.05 | 3.15K (Cr) | |
| ₹1685.90 | ₹1696.00 | ₹1650.35 | ₹1675.25 | 1.89L (Cr) | |
| ₹1680.00 | ₹1680.00 | ₹1662.55 | ₹1676.50 | 2.42K (Cr) | |
| ₹1708.90 | ₹1708.90 | ₹1670.00 | ₹1674.50 | 4.41K (Cr) | |
| ₹1815.00 | ₹1815.00 | ₹1731.00 | ₹1735.00 | 6.30K (Cr) | |
| ₹1849.95 | ₹1895.00 | ₹1821.20 | ₹1871.55 | 7.88K (Cr) | |
| ₹1810.00 | ₹1848.00 | ₹1810.00 | ₹1835.50 | 2.83K (Cr) |
BETA Technologies, Inc Class A Common Stock — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1815.00 | ₹1815.00 | ₹1529.00 | ₹1661.10 | -8.48% | |
| ₹1848.00 | ₹1895.00 | ₹1701.00 | ₹1871.55 | +1.27% | |
| ₹1864.65 | ₹1934.95 | ₹1770.10 | ₹1819.75 | -2.41% | |
| ₹1728.70 | ₹2000.00 | ₹1695.00 | ₹1874.00 | +8.41% |
AI Research Briefing
Powered by Gemini · 2026-04-08
BETA is a high-flying electric aviation stock trading at an unjustifiable valuation, making it a risky bet for investors.
WHAT'S HAPPENING NOW (last 2-4 weeks)
BETA Technologies reported full year 2025 revenue jumped to Cr from Cr in 2024, a roughly 136% increase. The company added over Cr to its commercial aircraft backlog and another Cr to its enabling technologies backlog during 2025. Citigroup issued a pessimistic forecast for BETA Technologies stock price.
CORE STORY (THE REAL GAME)
- Strong revenue growth of 136% in 2025
- Significant backlog exceeding ₹16,600 Cr
- Leading position in charging infrastructure
- Successful aircraft certification
- Major new government contracts
- Technological breakthrough in battery range
- Widening losses with negative ₹2,530 Cr adjusted EBITDA
- High cash burn rate
- Lofty valuation with uncertain profitability
Liberty Street Advisors acquired 999,202 shares in Q4, valued at ₹235 Cr, representing 47.15% of their AUM.
Government support for green technology provides a tailwind, but regulatory hurdles and infrastructure limitations remain headwinds.
Over ₹16,600 Cr in combined aircraft and enabling technologies backlog.
No. Free Cash Flow 5Y: ₹46.8 Cr
BETA needs to demonstrate a clear path to profitability within the next 2-3 years or risk a significant correction. Focus on monitoring cash burn and certification progress.
Primary Thesis Risk
Failure to achieve commercial scale and profitability will lead to a collapse in valuation.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
BETA Technologies, Inc Class A Common Stock Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
BETA Technologies, Inc Class A Common Stock Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BETA across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (18.78%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (19.16%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (21.06%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (27.08% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (28.67% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (28.76% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (64.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 56.33x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-15.18%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 8.96%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
BETA Technologies, Inc Class A Common Stock vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare BETA Technologies, Inc Class A Common Stock with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
52.1/100 | ₹1661.10₹1661 | ₹2336.55₹2336.55 | 56.33Average 56.3 Average | 18.78%Good 18.78% Good | 19.16%Good 19.16% Good | 0.60Good 0.6 Good | 28.76%Excellent 28.76% Excellent | 27.08%Excellent 27.08% Excellent | 0.00% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
BETA Technologies, Inc Class A Common Stock PE Ratio History
Historical price-to-earnings ratio for BETA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹36.10 | ₹2009.00 | 55.7x |
| FY 2023 | ₹30.43 | ₹1470.00 | 48.3x |
| FY 2022 | ₹24.59 | ₹710.00 | 28.9x |
| FY 2021 | ₹11.62 | ₹640.25 | 55.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
BETA Technologies, Inc Class A Common Stock Quarterly Performance
Latest quarterly metrics for BETA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
0.21%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-15.18%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
27.08%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
28.76%
Compounded annual net profit growth over 5 years
BETA Technologies, Inc Class A Common Stock Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BETA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
BETA Technologies, Inc Class A Common Stock Financial Statements
Annual income statement, balance sheet and cash flow for BETA Technologies, Inc Class A Common Stock (BETA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for BETA Technologies, Inc Class A Common Stock
About BETA (BETA Technologies, Inc Class A Common Stock)
BETA Technologies, Inc Class A Common Stock (BETA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceut...icals sector with a current market capitalisation of ₹2.34K (Cr). BETA Technologies, Inc Class A Common Stock has delivered a Return on Equity (ROE) of 18.78% and a ROCE of 19.16%. The debt-to-equity ratio stands at 0.60, reflecting the company's capital structure. Investors tracking BETA share price can monitor key metrics including P/E ratio, promoter holding of 64.63%, and quarterly earnings growth.
Company Details
BETA Share Price: Frequently Asked Questions
What is the current share price of BETA Technologies, Inc Class A Common Stock?
BETA Technologies, Inc Class A Common Stock (BETA) trades at ₹1661.10 on NSE. Market cap ₹2.34K (Cr). Educational data only.
What is the P/E ratio of BETA Technologies, Inc Class A Common Stock?
BETA Technologies, Inc Class A Common Stock has a P/E of 56.33x vs industry average 34.89x.
What is the Bull Run score for BETA Technologies, Inc Class A Common Stock?
BETA Technologies, Inc Class A Common Stock has a Bull Run score of 52.1/100 based on 25+ financial parameters.
Does BETA Technologies, Inc Class A Common Stock pay dividends?
BETA Technologies, Inc Class A Common Stock has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of BETA Technologies, Inc Class A Common Stock?
BETA Technologies, Inc Class A Common Stock has ROE of 18.78%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of BETA Technologies, Inc Class A Common Stock?
BETA Technologies, Inc Class A Common Stock has debt-to-equity of 0.60.
Is BETA Technologies, Inc Class A Common Stock a good investment?
Bull Run gives BETA Technologies, Inc Class A Common Stock a score of 52.1/100. This is not investment advice — consult a SEBI-registered advisor.